TAK
Takeda Pharmaceutical·NYSE
--
--(--)
--
--(--)
8.27 / 10
Outperform
Money flow analysis delivers an excellent 8.27/10 score, with strong positive trends across overall, block, small, large, and extra-large flows—only medium flow shows a mild negative bias. This robust inflow supports the stock and aligns with the positive sentiment noted in the four-pillar evaluation.
Fund Flow Rating
Is money flowing into or out of TAK?
- TAK holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.27/10 (Outperform).
